{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:07:28Z","timestamp":1789391248621,"version":"build-2803163510"},"reference-count":26,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Alpha-1 adrenergic receptor antagonists are widely used in the management of benign prostatic hyperplasia (BPH) . Their effects on blood pressure (BP) patterns remain incompletely characterized. This study aimed to prospectively evaluate the impact of tamsulosin on ambulatory blood pressure monitoring (ABPM) parameters, with particular focus on nocturnal BP load and dipping status. Methods: A total of 83 male patients aged 40\u201390 years who were initiated on tamsulosin for BPH-related lower urinary tract symptoms (LUTS) were prospectively enrolled; 58 patients with complete, technically adequate paired recordings were included in the final analysis. Participants underwent 24 h ABPM before treatment and at 1 month. Dipping status was defined as a nocturnal BP reduction \u226510%. Pre-post treatment ABPM parameters were compared using paired statistical analyses, and changes in dipping status were evaluated using McNemar\u2019s test. Results: Mean 24 h, daytime, and nighttime systolic and diastolic blood pressure (DBP) values did not change significantly after treatment (p &gt; 0.05). However, nocturnal systolic and DBP load decreased significantly following tamsulosin initiation (p = 0.035 and p = 0.005, respectively), along with a reduction in minimum DBP (p &lt; 0.001). Changes in dipping status were heterogeneous: 25% of baseline non-dippers converted to a dipper pattern, whereas 36.4% of initial dippers became non-dippers, with no statistically significant overall shift (p = 0.81). Conclusions: At one month, tamsulosin was not associated with significant changes in mean ambulatory BP. Reductions in nocturnal BP load were observed, but the incremental clinical significance of BP load beyond mean ambulatory BP indices is uncertain. The marked decrease in minimum DBP warrants cautious interpretation as a potential safety signal. These findings should be considered exploratory and require confirmation in controlled studies incorporating earlier and longer follow-up.<\/jats:p>","DOI":"10.3390\/jcm15187112","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:09:51Z","timestamp":1789387791000},"page":"7112","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Tamsulosin on Nocturnal Blood Pressure Load and Dipping Status: A Prospective Ambulatory Blood Pressure Monitoring Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1518-8371","authenticated-orcid":false,"given":"Cumhur","family":"Yesildal","sequence":"first","affiliation":[{"name":"Department of Urology, Sultan 2. Abd\u00fclhamid Han Training and Research Hospital, 34668 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5014-4641","authenticated-orcid":false,"given":"Anil","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Urology, Sultan 2. Abd\u00fclhamid Han Training and Research Hospital, 34668 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin","family":"Hayit","sequence":"additional","affiliation":[{"name":"Department of Urology, Sultan 2. Abd\u00fclhamid Han Training and Research Hospital, 34668 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0499-0078","authenticated-orcid":false,"given":"Nurgul","family":"Keskin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sultan 2. Abd\u00fclhamid Han Training and Research Hospital, 34668 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sultan 2. Abd\u00fclhamid Han Training and Research Hospital, 34668 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","article-title":"EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction","volume":"67","author":"Gratzke","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Mansbart, F., Kienberger, G., Sonnichsen, A., and Mann, E. (2022). Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: A systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing. BMC Geriatr., 22.","DOI":"10.1186\/s12877-022-03415-7"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/00325481.2015.1018799","article-title":"Benign prostatic hyperplasia and urinary symptoms: Evaluation and treatment","volume":"127","author":"Mobley","year":"2015","journal-title":"Postgrad. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"11116","DOI":"10.1038\/s41598-024-61977-5","article-title":"Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: A systematic review and network meta-analysis","volume":"14","author":"Yoosuf","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/HJH.0000000000002843","article-title":"2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement","volume":"39","author":"Stergiou","year":"2021","journal-title":"J. Hypertens."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.3906\/sag-2105-177","article-title":"Heart rate turbulence measurements in patients with dipper and non-dipper hypertension: The effects of autonomic functions","volume":"51","author":"Alp","year":"2021","journal-title":"Turk. J. Med. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1038\/s41440-021-00717-y","article-title":"Number and timing of ambulatory blood pressure monitoring measurements","volume":"44","author":"Jaeger","year":"2021","journal-title":"Hypertens. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J. Hypertens."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11906-023-01254-4","article-title":"Sympathetic Neural Mechanisms in Hypertension: Recent Insights","volume":"25","author":"Grassi","year":"2023","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_10","unstructured":"Nachawati, D., Leslie, S.W., and Patel, J.B. (2026). Alpha-Blockers. StatPearls, StatPearls Publishing."},{"key":"ref_11","first-page":"CD004643","article-title":"Blood pressure lowering efficacy of alpha blockers for primary hypertension","volume":"2012","author":"Heran","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000019639","article-title":"A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing","volume":"33","author":"Michel","year":"1998","journal-title":"Eur. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/CM9.0000000000002028","article-title":"Ambulatory blood pressure monitoring for the management of hypertension","volume":"135","author":"Cheng","year":"2022","journal-title":"Chin. Med. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1161\/HYPERTENSIONAHA.122.19996","article-title":"Pathophysiology of the Nondipping Blood Pressure Pattern","volume":"80","author":"Huart","year":"2023","journal-title":"Hypertension"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1081\/CBI-120037772","article-title":"Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects","volume":"21","author":"Hermida","year":"2004","journal-title":"Chronobiol. Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.35.3.787","article-title":"Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of \u03b1-adrenergic blocker, doxazosin: Results from the HALT study","volume":"35","author":"Kario","year":"2000","journal-title":"Hypertension"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.euf.2022.07.004","article-title":"Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression","volume":"9","author":"Gravas","year":"2023","journal-title":"Eur. Urol. Focus"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ucl.2021.12.003","article-title":"Medical Treatment of Benign Prostatic Hyperplasia","volume":"49","author":"Plochocki","year":"2022","journal-title":"Urol. Clin. N. Am."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.eururo.2006.06.016","article-title":"Alfuzosin (10 mg) does not affect blood pressure in young healthy men","volume":"50","author":"Mondaini","year":"2006","journal-title":"Eur. Urol."},{"key":"ref_20","first-page":"277","article-title":"Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive medications","volume":"10","author":"Zhang","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/HYPERTENSIONAHA.113.02780","article-title":"Blood pressure load does not add to ambulatory blood pressure level for cardiovascular risk stratification","volume":"63","author":"Li","year":"2014","journal-title":"Hypertension"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Eyal, O., and Ben-Dov, I.Z. (2023). The role of blood pressure load in ambulatory blood pressure monitoring in adults: A literature review of current evidence. Diagnostics, 13.","DOI":"10.3390\/diagnostics13152485"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Chen, J., Liu, Z., Yang, L., Zhou, J., Ma, K., Peng, Z., and Dong, Q. (2023). Relationship between nocturia and hypertension: Findings from the NHANES 2005-2016. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1165092"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1161\/HYPERTENSIONAHA.125.25497","article-title":"Effect of nocturia and sleep quality on sleep blood pressure: The HI-JAMP Study","volume":"82","author":"Tomitani","year":"2025","journal-title":"Hypertension"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41440-025-02136-9","article-title":"Nocturia and sleep blood pressure\u2014A key link in a vicious cycle?","volume":"48","author":"Nagai","year":"2025","journal-title":"Hypertens. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"f6320","DOI":"10.1136\/bmj.f6320","article-title":"Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: Risk window analyses using between and within patient methodology","volume":"347","author":"Bird","year":"2013","journal-title":"BMJ"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7112\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:50:41Z","timestamp":1789390241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":26,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15187112"],"URL":"https:\/\/doi.org\/10.3390\/jcm15187112","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]}}}